DEXCOM G7 GSS (161): payments to doctors
Payments that named DEXCOM G7 GSS (161) as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.2M
- Providers
- 4,916
- Transactions
- 10,115
- Average per transaction
- $519
The per-transaction average — $519 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,916 providers the average total is $1,067, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Dexcom, Inc. | $5,247,259 | 100.0% |